Citation Impact

Citing Papers

ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
2017 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Development of lipophilic cations as therapies for disorders due to mitochondrial dysfunction
2001
Presynaptic Modulation Controlling Neuronal Excitability and Epileptogenesis: Role of Kainate, Adenosine and Neuropeptide Y Receptors
2003
Astrocytes: biology and pathology
2009 Standout
The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease
2011 Standout
Tuberous sclerosis complex
2000 Standout
Insulin Activation of Rheb, a Mediator of mTOR/S6K/4E-BP Signaling, Is Inhibited by TSC1 and 2
2003 Standout
Parkinson disease
2017 Standout
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
2013 Standout
Nitric Oxide Scavenging by Hemoglobin or Nitric Oxide Synthase Inhibition by N-Nitro-L-Arginine Induces Cortical Spreading Ischemia When K+ Is Increased in the Subarachnoid Space
1998
The Tuberous Sclerosis Complex
2006 Standout
Tuberous Sclerosis and Multiple Tubers: Localizing the Epileptogenic Zone
2004
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
2009 Standout
Anterior, Total, and Two‐Stage Corpus Callosum Section: Differential and Incremental Seizure Responses
1993
Oxidative Stress Hypothesis in Alzheimer's Disease
1997 Standout
Diffusion-Weighted Magnetic Resonance Imaging and Identification of the Epileptogenic Tuber in Patients With Tuberous Sclerosis
2003
Glutamate uptake
2001 Standout
A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains
2001 Standout
Epilepsy surgery: patient-perceived long-term costs and benefits
2003
Neuroimaging in Parkinson disease: from research setting to clinical practice
2014
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
1992
Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009
2010 Standout
Neurodevelopmental Disorders as a Cause of Seizures: Neuropathologic, Genetic, and Mechanistic Considerations
2002
Perfusion Network Shift during Seizures in Medial Temporal Lobe Epilepsy
2013
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
A Temporoparietal and Prefrontal Network for Retrieving the Spatial Context of Lifelike Events
2001 StandoutNobel
Mitochondrial Encephalopathy, Lactic Acidosis, and Strokelike Episodes
2008
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions
1997
Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases
2002
The amygdala and intractable temporal lobe epilepsy
1996
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
Biological markers of intellectual disability in tuberous sclerosis
2007
The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol
2011
Parietal and Occipital Lobe Epilepsy: A Review
1993
The Relationship between Dorsolateral Prefrontal Neuronal N-Acetylaspartate and Evoked Release of Striatal Dopamine in Schizophrenia
2000
A Randomized, Controlled Trial of Surgery for Temporal-Lobe Epilepsy
2001 Standout
Dopamine control of seizure propagation: Intranigral dopamine D1 agonist SKF‐38393 enhances susceptibility of seizures
1990
Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers
2001
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
2009 Standout
Executive Functions and Developmental Psychopathology
1996 Standout
Frontal lobe phosphorus metabolism and neuropsychological function in aging and in alzheimer's disease
1995
The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia
1999
Cortical Excitability in Cryptogenic Localization‐Related Epilepsy: Interictal Transcranial Magnetic Stimulation Studies
2000
Magnetic Resonance Spectroscopy for Monitoring Neuronal Integrity in Amyotrophic Lateral Sclerosis
2006
Nonlinear Decrease over Time in N‐Acetyl Aspartate Levels in the Absence of Neuronal Loss and Increases in Glutamine and Glucose in Transgenic Huntington's Disease Mice
2000
Lysosomal Membrane Proteomics and Biogenesis of Lysosomes
2005
Proton Magnetic Resonance Spectroscopy: An Emerging Technology in Pediatric Neurology Research
1998
Pathogenesis and epidemiology of precocious puberty. Effects of exogenous oestrogens
2001
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
2007 Standout
Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases
2003
Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging☆
1999
MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed
2004
N-Acetylaspartate as a Marker of Neuronal Injury in Neurodegenerative Disease
2006
Epilepsy Surgery in Tuberous Sclerosis: A Systematic Review
2007
Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity
1995
Tuberous sclerosis
2008 Standout
BrainNet Viewer: A Network Visualization Tool for Human Brain Connectomics
2013 Standout
Consistent Localization of Interictal Epileptiform Activity on EEGs of Patients with Tuberous Sclerosis Complex
2005
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Effects of Coenzyme Q10 in Early Parkinson Disease
2002
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Epilepsy and quality of life in adults: A review of instruments
2005
Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis
2013
Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: A possible model for restless legs syndrome?
2000
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
The etiologic classification of epilepsy
2011
Functional organization of the hippocampal longitudinal axis
2014 StandoutNobel
Outcome Assessment in Epilepsy: Comparative Responsiveness of Quality of Life and Psychosocial Instruments
1997
Identification of the Epileptogenic Tuber in Patients with Tuberous Sclerosis: A Comparison of High‐resolution EEG and MEG
2006
Health‐related quality of life over time since resective epilepsy surgery
2007
The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function
2003 Standout
The Human Hippocampus and Spatial and Episodic Memory
2002 StandoutNobel
Surgery for Seizures
1996 Standout
Single gene disorders causing ischaemic stroke
2006
Selective Relationship Between Prefrontal N-Acetylaspartate Measures and Negative Symptoms in Schizophrenia
2000
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping
2003
Hippocampal Involvement in Spatial and Working Memory: A Structural MRI Analysis of Patients with Unilateral Mesial Temporal Lobe Sclerosis
1999
Transcranial Magnetic Stimulation: A Primer
2007 Standout
Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: A critical review and the UCLA experience
2009
Defective Brain Energy Metabolism Shown by in vivo 31P MR Spectroscopy in 28 Patients with Mitochondrial Cytopathies
1993
Brain Inflammation in Epilepsy: Experimental and Clinical Evidence
2005
Proton magnetic resonance spectroscopy in schizophrenia
1999
Neurotoxicity, Neuroplasticity, and Magnetic Resonance Imaging Morphometry
2002
Reversible decreases in N‐acetylaspartate after acute brain injury
1995
Large-scale brain networks and psychopathology: a unifying triple network model
2011 Standout
Epilepsy Surgery in Children with Tuberous Sclerosis Complex: Presurgical Evaluation and Outcome
2000
Hypothesis of the Postconcussive Vulnerable Brain: Experimental Evidence of Its Metabolic Occurrence
2005
Lipid‐lowering drugs and mitochondrial function: effects of HMG‐CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio
1996
Brain Abnormalities in Tuberous Sclerosis Complex
2004
N -Acetylaspartate Reduction as a Measure of Injury Severity and Mitochondrial Dysfunction Following Diffuse Traumatic Brain Injury
2001
The Protective Effect of Cyclosporin A upon N-Acetylaspartate and Mitochondrial Dysfunction following Experimental Diffuse Traumatic Brain Injury
2004
Oxidative damage and mitochondrial decay in aging.
1994 Standout
Update on Genetics of Stroke and Cerebrovascular Disease 2005
2006
Topical Review: Intractable Seizures in Tuberous Sclerosis Complex: From Molecular Pathogenesis to the Rationale for Treatment
2005
Managing Epilepsy in Tuberous Sclerosis Complex
2004
Magnesium in Man: Implications for Health and Disease
2014 Standout
Recognizing Syncope: Pitfalls and Surprises
1996
Molecular Pathogenesis of Tuber Formation in Tuberous Sclerosis Complex
2004
Alzheimer's disease
1998 Standout
N -Acetylaspartate in neuropsychiatric disorders
1995
Hallucinations: The science of idiosyncratic perception.
2008
Rasmussen??s Syndrome
2000
Magnetic resonance imaging evidence for a defect of cerebral cortical development in autism
1990
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Developmental outcome of epilepsy surgery in tuberous sclerosis complex
2005
Guidelines for the Primary Prevention of Stroke
2014 Standout
Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine
2000 Standout
Temporal lobectomy for epilepsy: Recovery of the contralateral hippocampus measured by 1 H MRS
2002
Pathophysiology of Migraine
2012
Magnetic source imaging localizes epileptogenic zone in children with tuberous sclerosis complex
2006
Cortical Activations During Auditory Verbal Hallucinations in Schizophrenia: A Coordinate-Based Meta-Analysis
2010 Standout
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
2008 Standout
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
An Updated Definition of Stroke for the 21st Century
2013 Standout
Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease.
2003
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
2015 Standout
Epilepsy Surgery for Children With Tuberous Sclerosis Complex
2004
Dysregulation of the TSC-mTOR pathway in human disease
2004 Standout
Creatine and Creatinine Metabolism
2000 Standout
Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.
2000 Standout

Works of F. Andermann being referenced

Neurology: A Queen Square Textbook
2009
Usefulness of focal rhythmic discharges on scalp EEG of patients with focal cortical dysplasia and intractable epilepsy
1996
Surgical treatment of epilepsy in tuberous sclerosis
1998
Focal cortical myoclonus and rolandic cortical dysplasia: Clarification by magnetic resonance imaging
1988
Specificity of Volumetric Magnetic Resonance Imaging in Detecting Hippocampal Sclerosis
1997
OCCIPITAL LOBE EPILEPSY: ELECTROCLINICAL MANIFESTATIONS, ELECTROCORTICOGRAPHY, CORTICAL STIMULATION AND OUTCOME IN 42 PATIENTS TREATED BETWEEN 1930 AND 1991
1992
The Relation of Spike Foci and of Clinical Seizure Characteristics to Different Patterns of Mesial Temporal Atrophy
1995
In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF)
1991
Psychosocial Consequences of Postoperative Seizure Relief
1993
Familiäre Kavernome des Zentralnervensystems
2004
Anterior callosotomy in the treatment of medically intractable epilepsies: A study of 43 patients with a mean follow‐up of 39 months
1991
Time Course of Postoperative Recovery of N‐Acetyl‐Aspartate in Temporal Lobe Epilepsy
2001
Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy
1999
Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy)
1994
Reflex seizures induced by calculation, card or board games, and spatial tasks
1990
Magnetic resonance imaging of hypothalamic hamartomas causing gelastic epilepsy
1992
The Causes of Epilepsy
2011
Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome
1991
Late‐onset drop attacks in temporal lobe epilepsy
1994
CCM1 mutation screen of sporadic cases with cerebral cavernous malformations
2004
Lateralizing value of peri-ictal headache: A study of 100 patients with partial epilepsy
2001
Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy
1997
Coenzyme Q 10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease
1993
Transient abolition of generalized photosensitive epileptic discharge in humans by apomorphine, a dopamine‐receptor agonist
1980
Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies
1993
G M1 ‐gangliosidosis without chondrodystrophy or visceromegaly
1970
Adult-onset epilepsy in focal cortical dysplasia of Taylor type
2005
Epilepsy and cortical cytoarchitectonic abnormalities: an attempt at correlating basic mechanisms with anatomoclinical syndromes.
1992
Rankless by CCL
2026